Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intervention to Reduce Phthalate and Bisphenol Exposure During the Critical Period of Minipuberty

NCT05864209 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05864209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05864209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intervention to Reduce Phthalate and Bisphenol Exposure During the Critical Period of Minipuberty
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
May 16, 2023
Completion date
January 11, 2024
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bisphenol exposure, phthalate exposure